Bertolino indicated a while ago that "our partners" are looking for method of action in the clinical trial for Kevetrin. Then the Phase 2 for Ovarian was stopped after 2 patients because they were able to document or confirm method of action. I keep thinking that something is going on behind the scenes with K and that we may all be surprised and see a K deal before a deal for B or P.....just a thought and IMHO.